Distrofia muscular de steinert pdf


A la distrofia muscular miotónica a menudo se le conoce simplemente como distrofia miotónica, y ocasionalmente se le llama enfermedad de Steinert, por el. complementan su trabajo, tal como la Asociación de la Distrofia Muscular (MDA), los .. Steinert. • Distrofia muscular miotónica (DMM). Nombre y abreviatura a. Descargar PDF Disease picture of myotonic muscular dystrophy in patients with large CTG Distrofia miotónica de Steinert ymalos resultados perinatales.

Language:English, Spanish, Portuguese
Country:Korea North
Genre:Fiction & Literature
Published (Last):08.04.2016
Distribution:Free* [*Registration Required]
Uploaded by: PEARLY

74918 downloads 174615 Views 31.52MB PDF Size Report

Distrofia Muscular De Steinert Pdf

pacientes con distrofia muscular de Becker y Duchenne con or incidencia 1 o distrofia muscular clásica (enfermedad de Steinert) de carácter congénito. Steinert myotonic dystrophy. Disease definition. Steinert disease, also known as myotonic dystrophy type 1, is a muscle Review article; Français (, pdf). PDF | Steinert disease is the most common muscular dystrophy of the adult. Due to its hemorroidectomia em paciente portador de distrofia muscular e dis-.

Full Text Introduction Myotonic dystrophy type 1 DM-1 , also known as Steinert disease, is a genetic disease caused by abnormal expansion of the cytosine-thymine-guanine CTG triplet in the DMPK dystrophia myotonica-protein kinase gene on chromosome 19, which is mainly expressed in skeletal and cardiac muscle. Although the main clinical manifestations of DM-1 are myotony and muscle weakness secondary to involvement of skeletal muscle, other organs and systems may be affected, particularly the cardiovascular and respiratory systems. There is evidence that conduction disturbances are the most frequent cardiac manifestation, but other complications have been reported, including tachyarrhythmias. Some authors argue that the degree of neurological involvement and CTG expansion size are directly related to the severity of conduction tissue disease. After application of the exclusion criteria other types of myotony or DM or failure to complete the consultation protocols , the final study population consisted of 31 patients. All the ECG recordings were assessed independently by two experienced observers in accordance with international guidelines. From hour Holter monitoring, performed according to the guidelines, 18 conduction and rhythm disturbances were identified, using Lown's classification to characterize ventricular ectopic beats. For analysis of the correlation between CTG expansion size and cardiac events, the sample was divided into two groups, equal to or below and above the median of repeats in the sample Possible gender differences were investigated. The means of quantitative variables for both sexes and correlation with CTG expansion size were compared using the Student's t test for independent samples, and the chi-square test or Fisher's exact test, as appropriate, were used for analysis of categorical variables. ResultsPopulation characteristics The final sample consisted of 31 patients, of whom 20 Mean age was Mean body mass index BMI was Table 1.

These individuals may develop any of the typical features of DM1 including weakness, myotonia, cataracts, and cardiac problems.

Strength improves during early childhood, then begins to decrease during the second decade [ Kroksmark et al ]. The cause of the intellectual disability is unclear, but cerebral atrophy and ventricular dilation are often evident at birth.


Delusions and psychotic features can occur [ Jacobs et al ]. Excessive daytime sleepiness can affect quality of life [ Ho et al ]. Genotype-Phenotype Correlations In general, longer CTG repeat expansions correlate with an earlier age of onset and more severe disease [ Logigian et al ] Table 2. Small but abnormal repeats are often associated with a mild or asymptomatic phenotype [ Arsenault et al ].

A person who was a compound heterozygote for expanded alleles with 1, and 60 CTG repeats was reported to have cerebral abnormalities [ Cerghet et al ]. However, mild cases e.

Doenças neuromusculares Neuromuscular disorders

Anticipation Because DMPK alleles of CTG length greater than 34 repeats are unstable and may expand in length during meiosis, at-risk offspring may inherit repeat lengths considerably longer than those present in the transmitting parent.

This phenomenon results in anticipation , the occurrence of increasing disease severity and decreasing age of onset in successive generations. Most often a child with early-onset, severe DM1 i. In a study of children of parents with small expansions CTG repeats , those with expanded alleles transmitted paternally had a larger increase in CTG repeats median: repeats; range: , than did those with maternally transmitted expanded alleles median: repeats; range: , [ Pratte et al ].

Prevalence Estimates of the prevalence of DM1 range from , in some areas of Japan to , in Iceland, with an overall estimated worldwide prevalence of , [ Theadom et al ]. Founder effects may increase the prevalence in specific regions, such as Quebec [ Yotova et al , Pratte et al ].

Differential Diagnosis Hypotonia in infancy is seen in many disorders, including Prader-Willi syndrome , multiminicore disease OMIM , , nemaline myopathy , X-linked centronuclear myopathy , other centronuclear myopathies OMIM PS , and maternal uniparental disomy for chromosome Although myotonia has been reported during the first decade, onset is typically in the third decade, most commonly with fluctuating or episodic muscle pain that can be debilitating and weakness of the neck flexors and finger flexors.

Subsequently, weakness occurs in the elbow extensors and the hip flexors and extensors. Facial weakness and weakness of the ankle dorsiflexors are less common.

Myotonia rarely causes severe symptoms. Inheritance is autosomal dominant. DM2 is the only other known genetic form of multisystem myotonic dystrophy identified to date although others likely exist.

Note: The International Myotonic Dystrophy Consortium IDMC has agreed that any newly identified multisystem myotonic dystrophies will be sequentially named as forms of myotonic dystrophy. One family posited to have DM3 [ Le Ber et al ] was subsequently shown to have an unusual presentation of inclusion body myopathy with Paget disease and frontotemporal dementia [ Udd et al ] caused by pathogenic variants in VCP.

Muscular Dystrophy / Atrophy

Hereditary distal myopathies. The differential diagnosis for hereditary distal myopathies includes GNE-related myopathy hereditary inclusion body myopathy 2 , myofibrillar myopathy OMIM PS , distal muscular dystrophy e. Hereditary myotonia.

Other hereditary disorders associated with myotonia are: myotonia congenita also called Thomsen disease or Becker disease , caused by pathogenic variants in CLCN1; paramyotonia congenita OMIM and its variants, caused by pathogenic variants in SCN4A; and hyperkalemic periodic paralysis , caused by pathogenic variants in SCN4A. Occasionally, DM1 has been misdiagnosed as motor neuron disease see Spinal Muscular Atrophy and Spinal and Bulbar Muscular Atrophy , cerebral palsy, nonspecific intellectual disability, or, because of "masked face" and slow movements, parkinsonism.

Management Evaluations Following Initial Diagnosis To establish the extent of disease and needs in adults with classic myotonic dystrophy type 1 DM1 , the evaluations summarized in Table 3 if not performed as part of the evaluation that led to the diagnosis are recommended. Consensus-based care recommendations for adults have been published [ Ashizawa et al ] and are available at www.

Table 3. The subclinical forms of this disease may go unnoticed and diagnosis can be late, triggered in many cases by the appearance of an early cataract 5 or after undergoing general anesthesia.

Several clinical cases of tumors in MD1 patient have been reported.

The most commonly described cancers are pilomatrixomas, although they can vary widely. To date, only 3 studies have attempted to clarify this possible association. One of these, based on patients with MD types 1 and 2 concluded that these patients had a higher risk of endometrial, ovarian, brain, and colon cancer, 1 and that the risk was higher in women and patients with MD1.

Gadalla, M. Lund, R.

Pfeiffer, S. Gortz, C. Mueller, R. J Neurol.

Seiji H. Ciliary and retinal changes in myotonic dystrophy. Arch Ophtalmol. Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 DM1 and type 2 DM2. Apathy and hypersomnia are common features of myotonic dystrophy. J Neurol Neurosurg Psychiatry. Cancer risk among patients with myotonic muscular dystrophy. Hypothesis: neoplasms in myotonic dystrophy. Cancer Causes Control. Increased cancer risks in myotonic dystrophy. Mayo Clin Proc.

Related articles:

Copyright © 2019 terney.info. All rights reserved.
DMCA |Contact Us